Carlisle Companies Incorporated (CSL)

Interest coverage

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 1,156,700 1,189,900 1,152,700 1,046,100 947,400 940,300 987,400 1,130,300 1,281,500 1,218,400 1,034,200 758,600 567,300 502,800 497,400 487,800 504,200 526,600 559,900 645,200
Interest expense (ttm) US$ in thousands 73,300 74,600 75,400 75,400 75,600 75,300 78,500 82,100 85,900 89,700 86,900 83,700 80,300 77,100 76,300 76,900 76,600 74,200 71,900 66,800
Interest coverage 15.78 15.95 15.29 13.87 12.53 12.49 12.58 13.77 14.92 13.58 11.90 9.06 7.06 6.52 6.52 6.34 6.58 7.10 7.79 9.66

December 31, 2024 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $1,156,700K ÷ $73,300K
= 15.78

The interest coverage ratio for Carlisle Companies Incorporated has shown a general trend of improvement over the recent quarters. The company's ability to cover its interest expenses has increased from 9.66 in March 2020 to a peak of 15.95 in September 2024. This indicates that Carlisle is in a stronger position to meet its interest obligations from its operating income.

The interest coverage ratio dipped slightly in the first quarter of 2023 but recovered quickly in the subsequent periods. The peak in coverage ratio in September 2024 suggests that Carlisle is efficiently managing its debt obligations and generating sufficient earnings to comfortably cover its interest expenses.

Overall, the increasing trend in the interest coverage ratio reflects positively on Carlisle's financial health and indicates a reduced risk of default due to inability to meet interest payments. Investors and creditors may view this trend positively as it demonstrates the company's solid financial performance and ability to service its debt effectively.


Peer comparison

Dec 31, 2024

Company name
Symbol
Interest coverage
Carlisle Companies Incorporated
CSL
15.78
West Pharmaceutical Services Inc
WST
127.04